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ABSTRACT
Objectives: Despite the extensive amount of published literature upon burning symptoms in patients with clinically 
healthy appearance of the oral mucosa, as well as burning mouth syndrome (BMS) itself, they both remain still cha-
llenging topics. 
The aim of this study was to determine the real prevalence of “true” BMS in comparison to other patients with burning 
symptoms with clinically healthy appearance of the oral mucosa and then to compare “true“ BMS patients with healthy 
controls regarding gastritis and intake of anxiolytics and angiotensin converting enzyme inhibitors.
Study design: In 150 patients with burning symptoms of clinically healthy oral mucosa, local and systemic investigations 
were performed and they included detection of candidal infection, salivary flow rate, presence of oral galvanism and 
parafunctional habits as well as complete blood count, serum ferritin, serum glucose levels, serum antibodies to Helico-
bacter pylori together with detailed medical history  with special regard to medication intake. 
After “true“ BMS patients were identified they have been compared to the controls with regard to the presence of gas-
tritis and the intake of anxiolytics and angiotensin  converting enzyme inhibitors. 
Results: Our results show that gastritis were significantly more present among “true” BMS patients and that they also 
significantly more intake anxiolitics, when compared to the control group.
Conclusions: Our  findings might lead to the conclusion that every “true“ BMS patient should be referred to the gas-
troenterologist and psychiatrist.
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INTRODUCTION
It is well known that symptoms of burning in the oral tissues 
are concomitant to certain oral diseases. However, burning 
symptoms might occur when oral mucosa has clinically 
healthy appearance. Additionally, in some of these patients 
underlying local and systemic conditions which could lead 
to symptoms of burning might be found, such as candidal 
infection, xerostomia, oral galvanism, parafunctional habit 
such as tongue thrusting, psychological and neurological 
disturbances, diabetes mellitus, menopause, side effects of 
drug therapy and paraneoplastic syndrome (1-14). Finally, 
in patients where these clinical and laboratory findings 
are lacking, diagnosis of  “true“ burning mouth syndro-
me (BMS) is established and that all the other burning 
symptoms are due to a different pathologies representing 
with one symptom within the clinical spectrum of such a 
group of pathologies  (15). The etiology of true BMS is 
still poorly understood, albeit extensive literature has been 
published in that area of the research. Recent studies have 
proposed neurological background and in the small group 
of  patients with BMS, Lauria et al. (16) have identified 
trigeminal small-fiber sensory neuropathy. Bartoshuk et 
al. (17) has reported that interactions between taste and 
oral pain are responsible for BMS and that the intensity 
of the peak oral pain correlated with the density of fungi-
form papillae. Additional problem regarding BMS is lack 
of  universally accepted definition based on the uniform 
criteria and sometimes even misunderstanding in the field 
of its terminology as Scala et al (15) concluded. Criteria 
for establishing a diagnosis of  “true” BMS was presence 
of  burning sensation on clinically healthy oral mucosa in 
the absence of all aforementioned known local and systemic 
etiological factors. 
Therefore, the aim of this study was to determine the real 
prevalence of “true” BMS in comparison to other patients 
with burning symptoms with clinically healthy appearance 
of the oral mucosa and compare them to healthy controls 
regarding the presence of gastritis and the intake of anxio-
lytics and angiotensin  converting enzyme inhibitors.
MATERIAL  AND METHODS
Prior to the investigation informed consent according to 
Helsinki II was obtained from each participant. Out of 
1399 patients who were referred to the Department of Oral 
medicine in Zagreb during the year 2001, 150 had burning 
symptoms in clinically healthy oral mucosa. There were 
123 women, age range 23 - 88, mean 64 years and 27 men, 
age range 30 - 77, mean 60.5 years. After detailed medical 
history was taken from each participant, thorough clinical 
examination of the oral cavity was performed. Smear for 
the detection of  Candida albicans was taken from each 
participant with a cotton stick. The smear was placed on 
the Saboraud’s agar into an incubator at the temperature 
of 37°C for 48 hours and then according to the number of 
colonies diagnosis of candidiasis was made according to 
Budtz-Jorgensen (18). Measurment of salivary flow rate 
was done by use of simple spitting method into calibrated 
tubes during 5 minutes while participants were sitting 
according to Navazesh et al. (19). Values lower than 0.2 ml 
per minute were considered as an indicator of xerostomia. 
Oral galvanism (electrochemical potential between various 
metals in the oral cavity) was measured with a specially 
constructed device-digital voltmeter and values higher than 
150 mV were considered as pathological (20). The presence 
of tongue thrusting habit was a sign of the parafunctional 
habit. Every patient underwent hematological screening for 
complete blood count with additional tests for blood glucose 
levels, serum ferritin and Helicobacter pylori antibodies. 
After all known local and systemic factors known to 
contribute to burning symptoms in clinically healthy oral 
mucosa  were excluded, the diagnosis of “true“ burning 
mouth syndrome was established in the remaining number 
of patients. Then they were compared to 80 sex and age 
matched controls recruited from the Department of 
Prosthodontics and free of  any oral disease and burning 
symptoms, regarding gastritis and the intake of angiotensin 
converting enzyme inhibitors and anxiolytics. The statistical 
analysis was performed by use of Chi-Square test and p 
values (p<0.05) were considered as significant.
RESULTS
Table 1. displays the results of clinical and laboratory testings 
conducted in  the study group. Factors associated with 
burning symptoms and clinically healthy oral mucosa are 
shown. Local factors were detected as follows: xerostomia 
in 58 (38.6%) patients, clinically invisible candidiasis in 58 
(38.6%) patients, parafunctional habits in 3 (2%) patients and 
oral galvanism in 7 (4.7%) patients, respectively. Systemic 
factors which might contribute to burning symptoms in 
clinically healthy oral mucosa were: Helicobacter pylori 
infection which was found in 19 (12.7%) patients, diabetes 
which was found in 20 (13.3%) patients, anemia which was 
found in 19 (12.7%) patients and neurological diseases such 
as Parkinson’s disease and cerebrovascular insult which were 
found in 5 (3.3%) patients (Table 1).
Xerostomia 58 38.6% 
Candidal infection 58 38.6% 
Parafunctional habits 3 2% 
Oral galvanism 7 4.7% 
Helicobacter pylori infection 19 12.7% 
Diabetes 20 13.3% 
Anemia 19 12.7% 
Neurological diseases 5 3.3% 
"True BMS" 76 50.7% 
Table 1. Factors associated with  burning symptoms found in the study 
group (total of  150 patients with burning symptoms and healthy oral 
mucosa).
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No significant difference between “true” BMS patients and 
controls regarding the intake of angiotensin  converting 
enzyme inhibitors was found. Significant differences 
between “true BMS” patients and controls were found 
regarding gastritis and the intake of  anxiolytics (p<0.05) 
(Table 2). 
DISCUSSION
The percentage of  patients with symptoms of  burning 
was 9.8% out of all the other patients who attended our 
Department, albeit one has to bear in mind that our sample 
is not representative of the general population because they 
were part of the stratified group. However, after exclusion 
of patients with burning symptoms and healthy oral mucosa 
due to other causes,  the number of “true“ BMS patients was 
5.4%. Bearing in mind that Croatia has 4 milion inhabitants 
it seems that true prevalence of BMS is from 0.002% - 4% 
(based on the average assumption of epidemiological data 
which is 3-4 times more than real numbers) of the general 
population. 
In almost half  of  the patients with burning mouth and 
clinically healthy oral mucosa at least two or more local or 
systemic factors which might lead to the burning symptoms 
were detected (Table1). 
After correction of etiological factors,15 out of 58 (24.1%) 
patients with xerostomia, 27 out of  58 (46.5%) patients 
with candidal infection, 2 out of 3 (66.7%) patients with 
parafunctional habits, 3 out of 7 (42.8%) patients with oral 
galvanism, 15 out of 19 (79 %) patients with Helicobacter 
pylori infection and 10 out of 19 (52.6 %) patients with 
anemia were free of burning symptoms.
In 76 patients out of 150 (50.7%), the diagnosis of  “true“ 
burning mouth syndrome was established. The results of our 
survey suggest that the majority of patients with burning 
symptoms are women (82%), older than 60 years which is 
in concordance with previous findings of other authors ( 
3, 5, 21,22). 
Then they were compared with 80 control group partici-
pants regarding the use of angiotensin  converting enzyme 
inhibitors and anxiolytics. Bearing in mind the results of 
Lamey et al (23) who reported that BMS patients were 3.2 
times more likely to have recurrent gastrointestinal problems 
than controls we also compared BMS patients with controls 
regarding the presence of gastritis. 
In this study 22 out of 76 “true“ BMS patients (28.9%) 
were taking angiotensin  converting enzyme inhibitors 
and 32 out of 76 (42.1%) were taking anxiolytics (Table 2). 
Significant difference (p<0.05) was found between the two 
tested groups regarding the use of anxioltics  where 42.1 % 
of “true“ BMS patients were taking them in comparison 
to the 16.3% of the controls. This finding was also reported 
in other studies (22-24) where the intake of anxiolytics was 
much more frequent in “true” BMS patients. Higher pro-
portion of psychological disorders, especially depression, in 
“true” BMS  patients was reported by Palacios-Sanchez (3) 
and  Soto Araya (7). We might hypothesize only that this 
finding might reflect either patients’ underlying anxiety or 
anxiety resulting from BMS, a dilemma always present in 
patients with chronic pain conditions. 
Significant difference regarding the presence of gastritis in 
“true“ BMS group (51.3%) compared to the 27.5% in the 
control group (p<0.05) was found (Table 2). That finding 
was previously reported in the literature by Basker et al. 
(25), Lamb et al. (26) and Dobrenic et al. (27). Maresky 
et al. (21) reported that special cognizance must be taken 
in patients with burning symptoms who suffer from hiatal 
hernia, reflux esophagitis and flatulence, although latter 
disturbances have not reached statistical significance in their 
study. However, at present it is not clear whether gastrointes-
tinal disturbances are exclusion criteria for the establishment 
of “true” BMS diagnosis or they are just another somatic 
symptom of  underlying emotional  difficulties as suggested 
by Lamey et al. (23).
In patients with symptoms of burning in the oral cavity 
and clinically healthy oral mucosa, clinical examination of 
the oral cavity, candidal swab, oral galvanism measurment, 
salivary flow rate and parafunctional habit investigations 
should be performed. Additionaly, hematological screening 
(with special attention to serum ferritin, blood glucose levels 
and Helycobacter pylori antibodies) should be performed to 
identify possible underlying disturbances. Detailed medical 
history should reveal any systemic factors which might re-
sult in symptoms of burning. Special emphasis should be 
addressed at infection with Helicobacter pylori due to very 
high percentage (79%) of patients whose burning symptoms 
resolved after erradication therapy. 
Then if  any of these known local and systemic causes could 
not be confirmed a  diagnosis of “true” burning mouth syn-
drome should be established, unfortunately still without a 
proven cause and a limited therapeutic options. Due to the 
significant difference in anxiolytics intake between “true” 
BMS and controls, psychological examination and counse-
lling should be offered to these patients. Additionally, due 
to the significantly higher prevalence of gastritis in patients 
with “true“ BMS together with the reported incidence of 
3.2 times more gastrointestinal symptoms in true BMS by 
Lamey et al. (21) we suggest that every patient with burning 
mouth should be referred to the gastroenterologist.
  BMS patients (%) Controls (%) 
Angiotensin  converting 
enzyme inhibitors 
28.9 21.5 
Anxiolytics 42.1* 16.3 
Gastritis 51.3* 27.5 
Table 2. Comparison between medication intake and gastritis in “true” 
BMS patients and controls.
*significant difference (p<0.05)
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